- Home
- Publications
- Publication Search
- Publication Details
Title
Breast cancer
Authors
Keywords
-
Journal
Nature Reviews Disease Primers
Volume 5, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-09-23
DOI
10.1038/s41572-019-0111-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identifying breast cancer susceptibility genes – a review of the genetic background in familial breast cancer
- (2019) Camilla Wendt et al. ACTA ONCOLOGICA
- A systematic review of international guidelines and recommendations for the genetic screening, diagnosis, genetic counseling, and treatment of BRCA-mutated breast cancer
- (2019) Carol Forbes et al. Cancer Management and Research
- Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial
- (2019) Shu-Lian Wang et al. LANCET ONCOLOGY
- Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial
- (2019) Michael Gnant et al. LANCET ONCOLOGY
- Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials
- (2019) Richard Gray et al. LANCET
- Emerging role of histone deacetylase inhibitors as anti-breast-cancer agents
- (2019) Meran Keshawa Ediriweera et al. DRUG DISCOVERY TODAY
- Prognostic models for breast cancer: a systematic review
- (2019) Minh Tung Phung et al. BMC CANCER
- St. Gallen/Vienna 2019: A Brief Summary of the Consensus Discussion on the Optimal Primary Breast Cancer Treatment
- (2019) Marija Balic et al. Breast Care
- Breast cancer risk of hormonal contraception: Counselling considering new evidence
- (2019) Lino Del Pup et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- “Between Uncertainties and Overtreatment”
- (2019) Orit Kaidar-Person et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- West German Study PlanB Trial: Adjuvant Four Cycles of Epirubicin and Cyclophosphamide Plus Docetaxel Versus Six Cycles of Docetaxel and Cyclophosphamide in HER2-Negative Early Breast Cancer
- (2019) Ulrike Nitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Capivasertib (AZD5363) plus fulvestrant versus placebo plus fulvestrant after relapse or progression on an aromatase inhibitor in metastatic ER-positive breast cancer (FAKTION): A randomized, double-blind, placebo-controlled, phase II trial.
- (2019) Robert Hugh Jones et al. JOURNAL OF CLINICAL ONCOLOGY
- SOPHIA primary analysis: A phase 3 (P3) study of margetuximab (M) + chemotherapy (C) versus trastuzumab (T) + C in patients (pts) with HER2+ metastatic (met) breast cancer (MBC) after prior anti-HER2 therapies (Tx).
- (2019) Hope S. Rugo et al. JOURNAL OF CLINICAL ONCOLOGY
- Neratinib + capecitabine versus lapatinib + capecitabine in patients with HER2+ metastatic breast cancer previously treated with ≥ 2 HER2-directed regimens: Findings from the multinational, randomized, phase III NALA trial.
- (2019) Cristina Saura et al. JOURNAL OF CLINICAL ONCOLOGY
- Alpelisib for PIK3CA-Mutated, Hormone Receptor–Positive Advanced Breast Cancer
- (2019) Fabrice André et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2019) F Cardoso et al. ANNALS OF ONCOLOGY
- 6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial
- (2019) Helena M Earl et al. LANCET
- Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 study
- (2019) Kenji Tamura et al. LANCET ONCOLOGY
- De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
- (2018) G Curigliano et al. ANNALS OF ONCOLOGY
- Unravelling triple-negative breast cancer molecular heterogeneity using an integrative multiomic analysis
- (2018) Y Bareche et al. ANNALS OF ONCOLOGY
- 4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†
- (2018) F Cardoso et al. ANNALS OF ONCOLOGY
- Impact of Breast Surgery in Primary Metastasized Breast Cancer
- (2018) Florian Fitzal et al. ANNALS OF SURGERY
- Abstract GS1-03: Peri-operative aromatase inhibitor treatment in determining or predicting longterm outcome in early breast cancer – The POETIC* Trial (CRUK/07/015)
- (2018) JFR Robertson et al. CANCER RESEARCH
- Abstract GS1-01: Increasing the dose density of adjuvant chemotherapy by shortening intervals between courses or by sequential drug administration significantly reduces both disease recurrence and breast cancer mortality: An EBCTCG meta-analysis of 21,000 women in 16 randomised trials
- (2018) R Gray et al. CANCER RESEARCH
- Inflammatory breast cancer: The pathologists' perspective
- (2018) G. Cserni et al. EJSO
- Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort
- (2018) Elisa Gobbini et al. EUROPEAN JOURNAL OF CANCER
- Progestin-only and combined oral contraceptives and receptor-defined premenopausal breast cancer risk: The Norwegian Women and Cancer Study
- (2018) Marit Busund et al. INTERNATIONAL JOURNAL OF CANCER
- Phase III study of taselisib (GDC-0032) + fulvestrant (FULV) v FULV in patients (pts) with estrogen receptor (ER)-positive, PIK3CA-mutant (MUT), locally advanced or metastatic breast cancer (MBC): Primary analysis from SANDPIPER.
- (2018) Jose Baselga et al. JOURNAL OF CLINICAL ONCOLOGY
- Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
- (2018) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- OUP accepted manuscript
- (2018) JNCI-Journal of the National Cancer Institute
- Association Between CHEK2*1100delC and Breast Cancer: A Systematic Review and Meta-Analysis
- (2018) Mingming Liang et al. Molecular Diagnosis & Therapy
- Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
- (2018) Prudence A. Francis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
- (2018) Joseph A. Sparano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Predictors for poor cosmetic outcome in patients with early stage breast cancer treated with breast conserving therapy: Results of the Young boost trial
- (2018) Patricia J.A.M. Brouwers et al. RADIOTHERAPY AND ONCOLOGY
- Individualization of post-mastectomy radiotherapy and regional nodal irradiation based on treatment response after neoadjuvant chemotherapy for breast cancer
- (2018) David Krug et al. STRAHLENTHERAPIE UND ONKOLOGIE
- X chromosome gain is related to increased androgen receptor expression in male breast cancer
- (2018) Enrico Di Oto et al. VIRCHOWS ARCHIV
- Health-related quality of life in Asian patients with breast cancer: a systematic review
- (2018) Peh Joo Ho et al. BMJ Open
- OUP accepted manuscript
- (2018) JNCI-Journal of the National Cancer Institute
- Effect of Adjuvant Trastuzumab for a Duration of 9 Weeks vs 1 Year With Concomitant Chemotherapy for Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
- (2018) Heikki Joensuu et al. JAMA Oncology
- The impact of legislation mandating breast density notification – Review of the evidence
- (2018) Nehmat Houssami et al. BREAST
- Male breast cancer: a disease distinct from female breast cancer
- (2018) Ayca Gucalp et al. BREAST CANCER RESEARCH AND TREATMENT
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- AZD5363 plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (PAKT): A randomised, double-blind, placebo-controlled, phase II trial.
- (2018) Peter Schmid et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant denosumab in early breast cancer: First results from the international multicenter randomized phase III placebo controlled D-CARE study.
- (2018) Robert E. Coleman et al. JOURNAL OF CLINICAL ONCOLOGY
- HER kinase inhibition in patients with HER2- and HER3-mutant cancers
- (2018) David M. Hyman et al. NATURE
- Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation
- (2018) Jennifer K. Litton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical value of circulating ESR1 mutations for patients with metastatic breast cancer: a meta-analysis
- (2018) Kai Zhang et al. Cancer Management and Research
- 193OAn international update of the EORTC questionnaire for assessing quality of life in breast cancer patients (EORTC QLQ-BC23) - EORTC QLQ-BR45
- (2018) V Bjelic-Radisic et al. ANNALS OF ONCOLOGY
- LBA3_PRAlpelisib (ALP) + fulvestrant (FUL) for advanced breast cancer (ABC): Results of the phase III SOLAR-1 trial
- (2018) F André et al. ANNALS OF ONCOLOGY
- Racial/ethnic differences in the outcomes of patients with metastatic breast cancer: contributions of demographic, socioeconomic, tumor and metastatic characteristics
- (2018) Jin-Xiao Ren et al. BREAST CANCER RESEARCH AND TREATMENT
- Accelerated partial breast irradiation: Current status with a focus on clinical practice
- (2018) Fabiana A. Miranda et al. Breast Journal
- Recommendations on screening for breast cancer in women aged 40–74 years who are not at increased risk for breast cancer
- (2018) Scott Klarenbach et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Breast Cancer Mortality in Older and Younger Breast Cancer Patients in California
- (2018) Li Tao et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Breast cancer in transgender patients: A systematic review. Part 1: Male to female
- (2018) Rebecca L. Hartley et al. EJSO
- Phenotypic and molecular dissection of metaplastic breast cancer and the prognostic implications
- (2018) Amy Ellen McCart Reed et al. JOURNAL OF PATHOLOGY
- Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial
- (2018) Galina Velikova et al. LANCET ONCOLOGY
- Current and future perspectives of liquid biopsies in genomics-driven oncology
- (2018) Ellen Heitzer et al. NATURE REVIEWS GENETICS
- Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer
- (2018) Nicholas C. Turner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
- (2018) Gunter von Minckwitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- ASCO, NCCN, MASCC/ESMO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in adult patients
- (2018) Yasmeen Razvi et al. SUPPORTIVE CARE IN CANCER
- A review of estrogen receptor/androgen receptor genomics in male breast cancer
- (2017) Tesa M Severson et al. ENDOCRINE-RELATED CANCER
- Primary metastatic breast cancer in the era of targeted therapy – Prognostic impact and the role of breast tumour surgery
- (2017) Jana Barinoff et al. EUROPEAN JOURNAL OF CANCER
- European Breast Cancer Conference manifesto on breast centres/units
- (2017) Fatima Cardoso et al. EUROPEAN JOURNAL OF CANCER
- Breast cancer risk and germline genomic profiling of women with neurofibromatosis type 1 who developed breast cancer
- (2017) Xia Wang et al. GENES CHROMOSOMES & CANCER
- Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
- (2017) Karoline B. Kuchenbaecker et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Improved systemic treatment for early breast cancer improves cure rates, modifies metastatic pattern and shortens post-metastatic survival: 35-year results from the Munich Cancer Registry
- (2017) Dieter Hölzel et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Anthracyclines in Early Breast Cancer: The ABC Trials—USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology)
- (2017) Joanne L. Blum et al. JOURNAL OF CLINICAL ONCOLOGY
- Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update
- (2017) Ian Krop et al. JOURNAL OF CLINICAL ONCOLOGY
- Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)
- (2017) Matthew J. Ellis et al. JOURNAL OF CLINICAL ONCOLOGY
- MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer
- (2017) Matthew P. Goetz et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of Cryotherapy on Objective and Subjective Symptoms of Paclitaxel-Induced Neuropathy: Prospective Self-Controlled Trial
- (2017) Akiko Hanai et al. JNCI-Journal of the National Cancer Institute
- The global burden of women’s cancers: a grand challenge in global health
- (2017) Ophira Ginsburg et al. LANCET
- Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) José Baselga et al. LANCET ONCOLOGY
- Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Miguel Martin et al. LANCET ONCOLOGY
- Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
- (2017) Sung-Bae Kim et al. LANCET ONCOLOGY
- Surgery of the primary tumor improves survival in women with stage IV breast cancer in Southwest China
- (2017) Yuxin Xie et al. MEDICINE
- 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
- (2017) Hongchao Pan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
- (2017) Mark Robson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy
- (2017) Norikazu Masuda et al. NEW ENGLAND JOURNAL OF MEDICINE
- Contemporary Hormonal Contraception and the Risk of Breast Cancer
- (2017) Lina S. Mørch et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer
- (2017) Gunter von Minckwitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer
- (2017) Maria Vittoria Dieci et al. SEMINARS IN CANCER BIOLOGY
- Effects of Cryotherapy on Objective and Subjective Symptoms of Paclitaxel-Induced Neuropathy: Prospective Self-Controlled Trial
- (2017) Akiko Hanai et al. JNCI-Journal of the National Cancer Institute
- Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer
- (2017) Fergus J. Couch et al. JAMA Oncology
- Germline Mutation Status, Pathological Complete Response, and Disease-Free Survival in Triple-Negative Breast Cancer
- (2017) Eric Hahnen et al. JAMA Oncology
- Overdiagnosis of breast cancer in population screening: does it make breast screening worthless?
- (2017) Houssami Nehmat et al. Cancer Biology & Medicine
- New insights into the metastatic behavior after breast cancer surgery, according to well-established clinicopathological variables and molecular subtypes
- (2017) Oreste Claudio Buonomo et al. PLoS One
- Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement
- (2016) Albert L. Siu et al. ANNALS OF INTERNAL MEDICINE
- Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Services Task Force
- (2016) Joy Melnikow et al. ANNALS OF INTERNAL MEDICINE
- Harms of Breast Cancer Screening: Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation
- (2016) Heidi D. Nelson et al. ANNALS OF INTERNAL MEDICINE
- Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 U.S. Preventive Services Task Force Recommendation
- (2016) Heidi D. Nelson et al. ANNALS OF INTERNAL MEDICINE
- Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial
- (2016) J. R. Mackey et al. ANNALS OF ONCOLOGY
- Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening†
- (2016) S. Paluch-Shimon et al. ANNALS OF ONCOLOGY
- Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases
- (2016) Armando E. Giuliano et al. ANNALS OF SURGERY
- Breast Conservation Therapy Versus Mastectomy: Shared Decision-Making Strategies and Overcoming Decisional Conflicts in Your Patients
- (2016) Julie A. Margenthaler et al. ANNALS OF SURGICAL ONCOLOGY
- Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update
- (2016) Abram Recht et al. ANNALS OF SURGICAL ONCOLOGY
- Reexcision Surgery for Breast Cancer: An Analysis of the American Society of Breast Surgeons (ASBrS) MasterySM Database Following the SSO-ASTRO “No Ink on Tumor” Guidelines
- (2016) Amanda M. Schulman et al. ANNALS OF SURGICAL ONCOLOGY
- DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1
- (2016) Y. Ogitani et al. CLINICAL CANCER RESEARCH
- Immuno-oncology: Allying forces of radio- and immuno-therapy to enhance cancer cell killing
- (2016) Jacques Bernier CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol
- (2016) Geeta Gulati et al. EUROPEAN HEART JOURNAL
- Survival of de novo stage IV breast cancer patients over three decades
- (2016) Dieter Hölzel et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Society of Surgical Oncology–American Society for Radiation Oncology–American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma In Situ
- (2016) Monica Morrow et al. JOURNAL OF CLINICAL ONCOLOGY
- Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline
- (2016) Hope S. Rugo et al. JOURNAL OF CLINICAL ONCOLOGY
- Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
- (2016) Lyndsay N. Harris et al. JOURNAL OF CLINICAL ONCOLOGY
- Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study
- (2016) Rita Nanda et al. JOURNAL OF CLINICAL ONCOLOGY
- American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline
- (2016) Carolyn D. Runowicz et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic Characterization of Primary Invasive Lobular Breast Cancer
- (2016) Christine Desmedt et al. JOURNAL OF CLINICAL ONCOLOGY
- DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer
- (2016) Lise Bech Jellesmark Thorsen et al. JOURNAL OF CLINICAL ONCOLOGY
- 18F-FDG PET/CT for Monitoring of Treatment Response in Breast Cancer
- (2016) S. Avril et al. JOURNAL OF NUCLEAR MEDICINE
- Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015
- (2016) Mary B. Daly et al. Journal of the National Comprehensive Cancer Network
- 5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial
- (2016) Luca Gianni et al. LANCET ONCOLOGY
- Landscape of somatic mutations in 560 breast cancer whole-genome sequences
- (2016) Serena Nik-Zainal et al. NATURE
- 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
- (2016) Fatima Cardoso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years
- (2016) Paul E. Goss et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
- (2016) Gabriel N. Hortobagyi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Palbociclib and Letrozole in Advanced Breast Cancer
- (2016) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1
- (2016) Birgitte V. Offersen et al. RADIOTHERAPY AND ONCOLOGY
- Updates on breast cancer genetics: Clinical implications of detecting syndromes of inherited increased susceptibility to breast cancer
- (2016) Erin F. Cobain et al. SEMINARS IN ONCOLOGY
- Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
- (2016) Brian D. Lehmann et al. PLoS One
- Should breathing adapted radiotherapy also be applied for right-sided breast irradiation?
- (2015) Marion Essers et al. ACTA ONCOLOGICA
- Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) E. Senkus et al. ANNALS OF ONCOLOGY
- Impact of Consensus Guidelines by the Society of Surgical Oncology and the American Society for Radiation Oncology on Margins for Breast-Conserving Surgery in Stages 1 and 2 Invasive Breast Cancer
- (2015) A. Chung et al. ANNALS OF SURGICAL ONCOLOGY
- Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysis
- (2015) Michael L. Marinovich et al. BMC CANCER
- Comparative effectiveness of imaging modalities to determine metastatic breast cancer treatment response
- (2015) Christoph I. Lee et al. BREAST
- Overall survival according to type of surgery in young (≤40 years) early breast cancer patients: A systematic meta-analysis comparing breast-conserving surgery versus mastectomy
- (2015) Jose Vila et al. BREAST
- Clinical implications of molecular heterogeneity in triple negative breast cancer
- (2015) Brian D. Lehmann et al. BREAST
- Advancing breast cancer survivorship among African-American women
- (2015) Steven S. Coughlin et al. BREAST CANCER RESEARCH AND TREATMENT
- Breast cancer statistics, 2015: Convergence of incidence rates between black and white women
- (2015) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Global Cancer Incidence and Mortality Rates and Trends--An Update
- (2015) L. A. Torre et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Unmet Information Needs and Quality of Life in Young Breast Cancer Survivors in Japan
- (2015) Mika Miyashita et al. CANCER NURSING
- Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer
- (2015) Giovanni Ciriello et al. CELL
- Liquid biopsy
- (2015) Isabelle Gingras et al. CURRENT OPINION IN ONCOLOGY
- Cancer Incidence in Five Continents: Inclusion criteria, highlights from Volume X and the global status of cancer registration
- (2015) F. Bray et al. INTERNATIONAL JOURNAL OF CANCER
- Breast Cancer Screening for Women at Average Risk
- (2015) Kevin C. Oeffinger et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Magnetic Resonance Imaging Improves Breast Screening Sensitivity in BRCA Mutation Carriers Age ≥ 50 Years: Evidence From an Individual Patient Data Meta-Analysis
- (2015) Xuan-Anh Phi et al. JOURNAL OF CLINICAL ONCOLOGY
- Electroacupuncture Versus Gabapentin for Hot Flashes Among Breast Cancer Survivors: A Randomized Placebo-Controlled Trial
- (2015) Jun J. Mao et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)
- (2015) William M. Sikov et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic landscape of adenoid cystic carcinoma of the breast
- (2015) Luciano G Martelotto et al. JOURNAL OF PATHOLOGY
- Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State
- (2015) Betsy A. Kohler et al. JNCI-Journal of the National Cancer Institute
- Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial
- (2015) Lucia Del Mastro et al. LANCET
- Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial
- (2015) Michael Gnant et al. LANCET
- Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials
- (2015) LANCET
- Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials
- (2015) LANCET
- Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)
- (2015) Claudia Allemani et al. LANCET
- Removing the primary tumour in metastatic breast cancer
- (2015) David Cameron LANCET ONCOLOGY
- Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial
- (2015) Rajendra Badwe et al. LANCET ONCOLOGY
- Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial
- (2015) Harry Bartelink et al. LANCET ONCOLOGY
- The debate over post-mastectomy radiotherapy should continue
- (2015) Caspian Oliai et al. Nature Reviews Clinical Oncology
- Clinical relevance of host immunity in breast cancer: from TILs to the clinic
- (2015) Peter Savas et al. Nature Reviews Clinical Oncology
- Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy
- (2015) Tari A. King et al. Nature Reviews Clinical Oncology
- Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer
- (2015) Sara M. Tolaney et al. NEW ENGLAND JOURNAL OF MEDICINE
- Breast-Cancer Screening — Viewpoint of the IARC Working Group
- (2015) Béatrice Lauby-Secretan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regional Nodal Irradiation in Early-Stage Breast Cancer
- (2015) Timothy J. Whelan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adjuvant Ovarian Suppression in Premenopausal Breast Cancer
- (2015) Prudence A. Francis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prospective Validation of a 21-Gene Expression Assay in Breast Cancer
- (2015) Joseph A. Sparano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer
- (2015) Philip M. Poortmans et al. NEW ENGLAND JOURNAL OF MEDICINE
- Defining Breast Cancer Intrinsic Subtypes by Quantitative Receptor Expression
- (2015) M. C. U. Cheang et al. ONCOLOGIST
- Role of Positron Emission Tomography for the Monitoring of Response to Therapy in Breast Cancer
- (2015) O. Humbert et al. ONCOLOGIST
- Racial and Ethnic Disparities in the Impact of Obesity on Breast Cancer Risk and Survival: A Global Perspective
- (2015) Elisa V Bandera et al. Advances in Nutrition
- Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods
- (2015) J. L. Carter et al. BMJ-British Medical Journal
- Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods
- (2015) J. L. Carter et al. BMJ-British Medical Journal
- Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State
- (2015) Betsy A. Kohler et al. JNCI-Journal of the National Cancer Institute
- EORTC QLQ-BR23 and FACT-B for the assessment of quality of life in patients with breast cancer: a literature review
- (2015) Jasmine Nguyen et al. Journal of Comparative Effectiveness Research
- Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12
- (2014) M. Gnant et al. ANNALS OF ONCOLOGY
- The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
- (2014) R. Salgado et al. ANNALS OF ONCOLOGY
- The Association of Surgical Margins and Local Recurrence in Women with Early-Stage Invasive Breast Cancer Treated with Breast-Conserving Therapy: A Meta-Analysis
- (2014) Nehmat Houssami et al. ANNALS OF SURGICAL ONCOLOGY
- A Closer Look at Unmet Needs at the End of Primary Treatment for Breast Cancer: A Longitudinal Pilot Study
- (2014) Jessica L. Burris et al. BEHAVIORAL MEDICINE
- Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer
- (2014) M. D. Burstein et al. CLINICAL CANCER RESEARCH
- A systematic review of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence
- (2014) M Pennant et al. HEALTH TECHNOLOGY ASSESSMENT
- Society of Surgical Oncology–American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer
- (2014) Meena S. Moran et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
- (2014) Sharon H. Giordano et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemotherapy and Targeted Therapy for Women With Human Epidermal Growth Factor Receptor 2–Negative (or unknown) Advanced Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
- (2014) Ann H. Partridge et al. JOURNAL OF CLINICAL ONCOLOGY
- Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
- (2014) Dawn L. Hershman et al. JOURNAL OF CLINICAL ONCOLOGY
- Postmastectomy radiation in breast cancer with one to three involved lymph nodes: ending the debate
- (2014) Philip Poortmans LANCET
- Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
- (2014) EBCTCG (Early Breast Cancer Trialists' Collaborative Group) LANCET
- Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
- (2014) Patricia Cortazar et al. LANCET
- Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
- (2014) Olivia Pagani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Patient-Reported Outcomes Measurement Information System (PROMIS): Efficient, standardized tools to measure self-reported health and quality of life
- (2014) Margaret Bevans et al. NURSING OUTLOOK
- Volumetric modulated arc therapy and breath-hold in image-guided locoregional left-sided breast irradiation
- (2014) Sarah O.S. Osman et al. RADIOTHERAPY AND ONCOLOGY
- Impact of analysis of frozen-section margin on reoperation rates in women undergoing lumpectomy for breast cancer: Evaluation of the National Surgical Quality Improvement Program data
- (2014) Judy C. Boughey et al. SURGERY
- First-line bevacizumab in combination with chemotherapy for HER2-negative metastatic breast cancer: pooled and subgroup analyses of data from 2447 patients
- (2013) D. W. Miles et al. ANNALS OF ONCOLOGY
- Aromatase inhibitor-induced arthralgia: a review
- (2013) P. Niravath ANNALS OF ONCOLOGY
- A Systematic Review of Oncoplastic Breast-Conserving Surgery
- (2013) Max H. Haloua et al. ANNALS OF SURGERY
- Supportive care after curative treatment for breast cancer (survivorship care): Resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement
- (2013) Patricia A. Ganz et al. BREAST
- Contralateral prophylactic mastectomy and survival: report from the National Cancer Data Base, 1998–2002
- (2013) Katharine Yao et al. BREAST CANCER RESEARCH AND TREATMENT
- Phase II Trial of Bicalutamide in Patients with Androgen Receptor-Positive, Estrogen Receptor-Negative Metastatic Breast Cancer
- (2013) A. Gucalp et al. CLINICAL CANCER RESEARCH
- Continued success in providing timely palliative radiation therapy at the Rapid Response Radiotherapy Program: a review of 2008–2012
- (2013) N. Thavarajah et al. Current Oncology
- Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial
- (2013) R.W. Blamey et al. EUROPEAN JOURNAL OF CANCER
- A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases
- (2013) Gaetano Aurilio et al. EUROPEAN JOURNAL OF CANCER
- Effect of mammography screening on surgical treatment for breast cancer: a nationwide analysis of hospitalization rates in Germany 2005–2009
- (2013) Andreas Stang et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
- (2013) Ellen M. Lavoie Smith et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Randomized Phase II, Double-Blind, Placebo-Controlled Study of Exemestane With or Without Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Treatment With a Nonsteroidal Aromatase Inhibitor
- (2013) Denise A. Yardley et al. JOURNAL OF CLINICAL ONCOLOGY
- Exposures to Synthetic Estrogens at Different Times During the Life, and Their Effect on Breast Cancer Risk
- (2013) Leena Hilakivi-Clarke et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Supportive Cryotherapy: A Review From Head to Toe
- (2013) Kunal C. Kadakia et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Meta-Analysis of Magnetic Resonance Imaging in Detecting Residual Breast Cancer After Neoadjuvant Therapy
- (2013) Michael L. Marinovich et al. JNCI-Journal of the National Cancer Institute
- 2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial
- (2013) Aron Goldhirsch et al. LANCET
- Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial
- (2013) Jayant S Vaidya et al. LANCET
- Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial
- (2013) Umberto Veronesi et al. LANCET ONCOLOGY
- The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials
- (2013) Joanne S Haviland et al. LANCET ONCOLOGY
- 6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial
- (2013) Xavier Pivot et al. LANCET ONCOLOGY
- Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study
- (2013) Thorsten Kuehn et al. LANCET ONCOLOGY
- Single versus multiple fractions of repeat radiation for painful bone metastases: a randomised, controlled, non-inferiority trial
- (2013) Edward Chow et al. LANCET ONCOLOGY
- Surgical Management of the Breast
- (2013) Sarah A. McLaughlin SURGICAL CLINICS OF NORTH AMERICA
- WSG ADAPT – adjuvant dynamic marker-adjusted personalized therapy trial optimizing risk assessment and therapy response prediction in early breast cancer: study protocol for a prospective, multi-center, controlled, non-blinded, randomized, investigator initiated phase II/III trial
- (2013) Daniel Hofmann et al. Trials
- Early prediction of pathologic response to neoadjuvant therapy in breast cancer: Systematic review of the accuracy of MRI
- (2012) M.L. Marinovich et al. BREAST
- Predictors of Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From Combined Analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27
- (2012) Eleftherios P. Mamounas et al. JOURNAL OF CLINICAL ONCOLOGY
- Whole-genome analysis informs breast cancer response to aromatase inhibition
- (2012) Matthew J. Ellis et al. NATURE
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Surgical Margins in Lumpectomy for Breast Cancer — Bigger Is Not Better
- (2012) Monica Morrow et al. NEW ENGLAND JOURNAL OF MEDICINE
- An “elite hacker”
- (2012) Aaron Boudreau et al. Cell Adhesion & Migration
- BRCA in breast cancer: ESMO Clinical Practice Guidelines
- (2011) J. Balmana et al. ANNALS OF ONCOLOGY
- Preoperative Ultrasound-Guided Needle Biopsy of Axillary Nodes in Invasive Breast Cancer
- (2011) Nehmat Houssami et al. ANNALS OF SURGERY
- Secretory Breast Carcinoma: Unique, Triple-Negative Carcinoma With a Favorable Prognosis and Characteristic Molecular Expression
- (2011) Pooja Vasudev et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Breast cancer in a multi-ethnic Asian setting: Results from the Singapore–Malaysia hospital-based breast cancer registry
- (2011) Nirmala Bhoo Pathy et al. BREAST
- Risk factors for lymphedema in breast cancer survivors, the Iowa Women’s Health Study
- (2011) Rehana L. Ahmed et al. BREAST CANCER RESEARCH AND TREATMENT
- A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer
- (2011) P N Munster et al. BRITISH JOURNAL OF CANCER
- The prognostic significance of lymphovascular invasion in invasive breast carcinoma
- (2011) Emad A. Rakha et al. CANCER
- Moderate Alcohol Consumption During Adult Life, Drinking Patterns, and Breast Cancer Risk
- (2011) Wendy Y. Chen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis
- (2011) Armando E. Giuliano JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Physical and Psychosocial Recovery in the Year After Primary Treatment of Breast Cancer
- (2011) Patricia A. Ganz et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
- (2011) M. Dowsett et al. JNCI-Journal of the National Cancer Institute
- MRI for breast cancer screening, diagnosis, and treatment
- (2011) Monica Morrow et al. LANCET
- Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study
- (2011) Karen A Gelmon et al. LANCET ONCOLOGY
- Local treatment of metastatic cancer—killing the seed or disturbing the soil?
- (2011) Scott C. Morgan et al. Nature Reviews Clinical Oncology
- Leukocyte composition of human breast cancer
- (2011) B. Ruffell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Quality Indicators for Breast Cancer: Revisiting Historical Evidence in the Context of Technology Changes
- (2011) Philip Poortmans et al. SEMINARS IN RADIATION ONCOLOGY
- International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment
- (2010) S. Dawood et al. ANNALS OF ONCOLOGY
- Improving Breast Cancer Surgery: A Classification and Quadrant per Quadrant Atlas for Oncoplastic Surgery
- (2010) Krishna B. Clough et al. ANNALS OF SURGICAL ONCOLOGY
- Magnetic resonance imaging of the breast: Recommendations from the EUSOMA working group
- (2010) Francesco Sardanelli et al. EUROPEAN JOURNAL OF CANCER
- Breast cancer precursors revisited: molecular features and progression pathways
- (2010) Maria A Lopez-Garcia et al. HISTOPATHOLOGY
- Effect of Endocrine Therapies on Bone in Breast Cancer Patients
- (2010) R. J. Santen JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Multidisciplinary Meeting on Male Breast Cancer: Summary and Research Recommendations
- (2010) Larissa A. Korde et al. JOURNAL OF CLINICAL ONCOLOGY
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. JOURNAL OF CLINICAL ONCOLOGY
- The molecular pathology of breast cancer progression
- (2010) Alessandro Bombonati et al. JOURNAL OF PATHOLOGY
- Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial
- (2010) David N Krag et al. LANCET ONCOLOGY
- Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer
- (2010) Timothy J. Whelan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: Recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009)
- (2010) Csaba Polgár et al. RADIOTHERAPY AND ONCOLOGY
- Is Breast Cancer the Same Disease in Asian and Western Countries?
- (2010) Stanley P. L. Leong et al. WORLD JOURNAL OF SURGERY
- Randomized Trial Comparing Locoregional Resection of Primary Tumor with No Surgery in Stage IV Breast Cancer at the Presentation (Protocol MF07-01): A Study of Turkish Federation of the National Societies for Breast Diseases
- (2009) Atilla Soran et al. Breast Journal
- Standardized synoptic cancer pathology reporting: A population-based approach
- (2009) John R. Srigley et al. JOURNAL OF SURGICAL ONCOLOGY
- BRCA1 and its toolbox for the maintenance of genome integrity
- (2009) Michael S.Y. Huen et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items
- (2009) Ron D. Hays et al. QUALITY OF LIFE RESEARCH
- Predicting EuroQol (EQ-5D) scores from the patient-reported outcomes measurement information system (PROMIS) global items and domain item banks in a United States sample
- (2009) Dennis A. Revicki et al. QUALITY OF LIFE RESEARCH
- Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27
- (2008) Priya Rastogi et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Trial of a Hypnosis Intervention for Treatment of Hot Flashes Among Breast Cancer Survivors
- (2008) Gary Elkins et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started